KR840002819A - 벤조티아제핀 유도체의 제조방법 - Google Patents
벤조티아제핀 유도체의 제조방법 Download PDFInfo
- Publication number
- KR840002819A KR840002819A KR1019820005453A KR820005453A KR840002819A KR 840002819 A KR840002819 A KR 840002819A KR 1019820005453 A KR1019820005453 A KR 1019820005453A KR 820005453 A KR820005453 A KR 820005453A KR 840002819 A KR840002819 A KR 840002819A
- Authority
- KR
- South Korea
- Prior art keywords
- acetone
- lower alkyl
- mixture
- formula
- compound
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D281/00—Heterocyclic compounds containing rings of more than six members having one nitrogen atom and one sulfur atom as the only ring hetero atoms
- C07D281/02—Seven-membered rings
- C07D281/04—Seven-membered rings having the hetero atoms in positions 1 and 4
- C07D281/08—Seven-membered rings having the hetero atoms in positions 1 and 4 condensed with carbocyclic rings or ring systems
- C07D281/10—Seven-membered rings having the hetero atoms in positions 1 and 4 condensed with carbocyclic rings or ring systems condensed with one six-membered ring
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/08—Vasodilators for multiple indications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Heart & Thoracic Surgery (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Cardiology (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Urology & Nephrology (AREA)
- Vascular Medicine (AREA)
- Nitrogen- Or Sulfur-Containing Heterocyclic Ring Compounds With Rings Of Six Or More Members (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Epoxy Resins (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Plural Heterocyclic Compounds (AREA)
- Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
Abstract
Description
Claims (7)
- 다음 일반식(Ⅱ)의 화합물을 아세톤 중 수산화 칼륨의 존재하에서 또는 아세톤, 저급 알킬 아세테이트, 아세톤 및 문의 혼합물 및 저급 알킬 아세테이트 및 물의 혼합물로부터 선택한 용매중 탄산칼륨의 존재하에서 2-(디메틸아미노)-에틸할리드와 죽합시키고, 필요하다면, 생성물을 이의 약학적으로 허용되는 산 부가염으로 전환시킴을 특징으로 하는, 다음 일반식(Ⅰ)의 벤조티아제핀 유도체 또는 이의 약학적으로 허용되는 산 부가염의 제조방법.상기식에서R은 수소 또는 아세틸이다.
- 제1항에 있어서, 축합을 아세톤중 일반식(Ⅱ)의 화합물 몰당 수산화칼륜 1내지 3몰의 존재하에 30℃내지 아세톤의 환류온도에서 또는 아세톤, 저급 알킬 아세테이트, 아세톤 및 물의 혼합물 및 저급 알킬 아세테이트 및 물의 혼합물로부터 선택한 용매중 일반식(Ⅱ)의 화합물 몰당 탄산칼륨 1내지 5몰의 존재하에 30℃내지 사용한 용매의 환류 온도에서 진행시키는 방법.
- 제1또는 2항에 있어서, 수산화칼륨 및 아세톤을 사용할때에는, 축합을 일반식(Ⅱ)의 화합물, 2-(디메틸아미노)에틸 클로라이드, 수산화칼륨 및 아세톤의 혼합물을 40내지 57℃에서 교반함으로서 진행시키고; 탄산 칼륨 및 아세톤 또는 저급알킬 아세테이트를 사용할때에는, 축합을 일반식(Ⅱ)의 화합물, 2-(디메틸아미노)에틸 클로라이드, 탄산칼륨 및 아세톤 또는 저급 알킬 아세테이트의 혼합물을 환류함으로써 진행시키고; 탄산칼륨 및 아세톤 및 물의 혼합물 또는 저급 알킬 아세테이트 및 물의 혼합물을 사용할 때에는, 축합을 일반식(Ⅱ)의 화합물, 2-(디메틸아미노)에틸 클로라이드, 탄산 칼륨 및 아세톤 또는 저급 알킬 아세테이트의 혼합물을 환류하고, 이 혼합물에 물을 가한후 이수성 혼합물을 더욱 환류함으로써 진행시키는 방법.
- 제1또는 2항에 있어서, 저급알킬 아세테이트가 메틸 아세테이트 또는 에틸 아세테이트인 방법.
- 제3항에 있어서, 저급 알킬 아세테이트가 메틸 아세테이트 또는 에틸 아세테이트인 방법.
- 제3항에 있어서, 2-(디메틸아미노)에틸 클로라이드를 이의 염산염 형태로 사용하는 방법.
- 제6항에 있어서, 수산화나트륨의 양이 일반식(Ⅱ)의 화합물 몰당 2내지 2.5몰이고, 탄산칼륨의 양이 일반식(Ⅱ)의 화합물 몰당 2내지 3몰인 방법.※ 참고사항 : 최초출원 내용에 의하여 공개하는 것임.
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP56197358A JPS5899471A (ja) | 1981-12-07 | 1981-12-07 | ベンゾチアゼピン誘導体の新規製造法 |
| JP56-197358 | 1981-12-07 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| KR840002819A true KR840002819A (ko) | 1984-07-21 |
| KR860002034B1 KR860002034B1 (ko) | 1986-11-17 |
Family
ID=16373149
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| KR8205453A Expired KR860002034B1 (ko) | 1981-12-07 | 1982-12-06 | 벤조티아제핀 유도체의 제조방법 |
Country Status (15)
| Country | Link |
|---|---|
| US (1) | US4438035B1 (ko) |
| EP (1) | EP0081234B1 (ko) |
| JP (1) | JPS5899471A (ko) |
| KR (1) | KR860002034B1 (ko) |
| AT (1) | ATE15799T1 (ko) |
| BG (1) | BG38937A3 (ko) |
| CA (1) | CA1177075A (ko) |
| DE (1) | DE3266583D1 (ko) |
| DK (1) | DK154022C (ko) |
| ES (1) | ES517966A0 (ko) |
| FI (1) | FI79705C (ko) |
| HK (1) | HK95488A (ko) |
| HU (1) | HU187431B (ko) |
| IE (1) | IE54241B1 (ko) |
| SU (1) | SU1176839A3 (ko) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US11241379B2 (en) | 2015-12-01 | 2022-02-08 | Sun Pharmaceutical Industries Limited | Parenteral dosage form of diltiazem |
Families Citing this family (23)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB8316032D0 (en) * | 1983-06-11 | 1983-07-13 | Tanabe Seiyaku Co | Benzothiazepine derivatives |
| IT1206505B (it) * | 1983-07-22 | 1989-04-27 | Schiapparelli Farma | Nuovi derivati benzotiazepinonici, metodo per la loro preparazione e composizioni farmaceutiche che licontengono. |
| GB2154577A (en) * | 1984-02-18 | 1985-09-11 | Tanabe Seiyaku Co | 1,5-benzothiazepines |
| IL71538A (en) * | 1984-04-13 | 1987-07-31 | Abic Ltd | Process for the preparation of benzothiazepine derivatives |
| US4758954A (en) * | 1984-07-25 | 1988-07-19 | Computer Services Corporation | Method of adjusting ticket fares |
| US4652561A (en) * | 1986-02-26 | 1987-03-24 | Hoffmann-La Roche Inc. | Naphtho[1,2-b]-1,4-thiazepinones |
| IL81954A0 (en) * | 1986-03-24 | 1987-10-20 | Hoffmann La Roche | Naphthothiazocinones,their manufacture and pharmaceutical compositions containing them |
| US4871731A (en) * | 1987-10-07 | 1989-10-03 | Marion Laboratories, Inc. | Captopril and diltiazem composition and the like |
| US4808580A (en) * | 1987-12-17 | 1989-02-28 | Hoffmann-La Roche Inc. | Naphtho[1,2-b][1,4]thiazepin-4(5H)-ones and use thereof in treatment of ischemia and blood pressure lowering |
| IT1226301B (it) * | 1988-07-26 | 1990-12-27 | Zambon Spa | Processo per la preparazione di intermedi per la sintesi del diltiazem. |
| FR2641535B1 (fr) * | 1989-01-11 | 1991-03-15 | Synthelabo | Procede de preparation de (+) - (2s, 3s)-hydroxy-3 (methoxy-4 phenyl)-2 dihydro-2,3 5h-benzothiazepine-1,5 one-4 |
| USRE34935E (en) * | 1989-01-11 | 1995-05-09 | Synthelabo | Method for preparing (+)-(2S,3S)-3-hydroxy-2-(4-methoxyphenyl)-2,3-dihydro-5H-1,5-benzothiazepine-4-one and chlorinated derivatives thereof |
| US5128469A (en) * | 1989-04-28 | 1992-07-07 | Tanabe Seiyaku Co., Ltd. | Process for preparing 1,5-benzothiazepine derivatives |
| JPH085869B2 (ja) * | 1990-03-08 | 1996-01-24 | 田辺製薬株式会社 | 1,5−ベンゾチアゼピン誘導体の製法 |
| NL9000763A (nl) * | 1990-03-31 | 1991-10-16 | Stamicarbon | Werkwijze voor het bereiden van 1,5-benzothiazepine-derivaten. |
| IT1255545B (it) * | 1992-10-23 | 1995-11-09 | Procedimento per la preparazione di diltiazem | |
| ATE167858T1 (de) * | 1994-09-16 | 1998-07-15 | Orion Corp Fermion | Verfahren zur herstellung von pharmazeutisch aktiven benzothiazepinderivaten. |
| FI97725C (fi) * | 1995-02-17 | 1997-02-10 | Orion Yhtymae Oy | Menetelmä diltiatseemin valmistamiseksi |
| WO1996038429A1 (en) * | 1995-06-01 | 1996-12-05 | Acic (Canada) Inc. | Method for the manufacture of benzothiazepine derivatives |
| US5559229A (en) * | 1995-06-01 | 1996-09-24 | Acic (Canada) Inc. | Method for the manufacture of benzothiazepine |
| SG50796A1 (en) * | 1996-02-23 | 1998-07-20 | Tanabe Seiyaku Co | Process for preparing 1,5-benzothiazepine derivative |
| TW438787B (en) | 1997-02-27 | 2001-06-07 | Tanabe Seiyaku Co | Process for preparing optically active trans-3-substituted glycidic acid ester |
| US6635277B2 (en) | 2000-04-12 | 2003-10-21 | Wockhardt Limited | Composition for pulsatile delivery of diltiazem and process of manufacture |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3075967A (en) * | 1961-06-12 | 1963-01-29 | Olin Mathieson | Benzothiazines |
| US3562257A (en) | 1967-10-28 | 1971-02-09 | Tanabe Seiyaku Co | Benzothiazepine derivatives |
| JPS57106673A (en) * | 1980-12-24 | 1982-07-02 | Chugai Pharmaceut Co Ltd | Dibenzo(b,f)(1,4)oxazepin derivative |
-
1981
- 1981-12-07 JP JP56197358A patent/JPS5899471A/ja active Granted
-
1982
- 1982-11-29 IE IE2836/82A patent/IE54241B1/en not_active IP Right Cessation
- 1982-11-30 CA CA000416635A patent/CA1177075A/en not_active Expired
- 1982-12-01 US US06445964 patent/US4438035B1/en not_active Expired - Lifetime
- 1982-12-03 FI FI824165A patent/FI79705C/fi not_active IP Right Cessation
- 1982-12-06 DK DK540382A patent/DK154022C/da not_active IP Right Cessation
- 1982-12-06 SU SU823524316A patent/SU1176839A3/ru active
- 1982-12-06 BG BG058822A patent/BG38937A3/xx unknown
- 1982-12-06 HU HU823912A patent/HU187431B/hu unknown
- 1982-12-06 KR KR8205453A patent/KR860002034B1/ko not_active Expired
- 1982-12-06 ES ES517966A patent/ES517966A0/es active Granted
- 1982-12-07 DE DE8282111317T patent/DE3266583D1/de not_active Expired
- 1982-12-07 AT AT82111317T patent/ATE15799T1/de not_active IP Right Cessation
- 1982-12-07 EP EP82111317A patent/EP0081234B1/en not_active Expired
-
1988
- 1988-11-24 HK HK954/88A patent/HK95488A/en not_active IP Right Cessation
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US11241379B2 (en) | 2015-12-01 | 2022-02-08 | Sun Pharmaceutical Industries Limited | Parenteral dosage form of diltiazem |
Also Published As
| Publication number | Publication date |
|---|---|
| HU187431B (en) | 1986-01-28 |
| DK154022B (da) | 1988-10-03 |
| ES8401953A1 (es) | 1984-01-01 |
| JPS5899471A (ja) | 1983-06-13 |
| KR860002034B1 (ko) | 1986-11-17 |
| IE54241B1 (en) | 1989-08-02 |
| FI824165L (fi) | 1983-06-08 |
| ATE15799T1 (de) | 1985-10-15 |
| FI824165A0 (fi) | 1982-12-03 |
| HK95488A (en) | 1988-12-02 |
| DE3266583D1 (en) | 1985-10-31 |
| DK540382A (da) | 1983-06-08 |
| US4438035A (en) | 1984-03-20 |
| CA1177075A (en) | 1984-10-30 |
| FI79705B (fi) | 1989-10-31 |
| EP0081234A1 (en) | 1983-06-15 |
| US4438035B1 (en) | 1994-07-26 |
| ES517966A0 (es) | 1984-01-01 |
| FI79705C (fi) | 1990-02-12 |
| BG38937A3 (en) | 1986-03-14 |
| DK154022C (da) | 1989-02-20 |
| EP0081234B1 (en) | 1985-09-25 |
| IE822836L (en) | 1983-06-07 |
| JPS6317832B2 (ko) | 1988-04-15 |
| SU1176839A3 (ru) | 1985-08-30 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| KR840002819A (ko) | 벤조티아제핀 유도체의 제조방법 | |
| KR850000406A (ko) | 4-클로로-2-페닐이미다졸-5-아세트산유도체의 제조방법 | |
| KR940014440A (ko) | 수용액에서의 치환도가 중간인 전분에스테르 및 그 제조방법 | |
| KR830004315A (ko) | 아실 유도체의 제조방법 | |
| KR850005845A (ko) | 7-아미노-3-치환된-메틸-3-세펨-4-카복실산 및 그의 저급 알킬실릴 유도체의 제조방법 | |
| KR850004754A (ko) | 3-인돌 카르복사미드 화합물류의 제조방법 | |
| KR880701234A (ko) | 신규 비페닐 유도체와 그의 제조 방법 및 용도 | |
| KR840001152A (ko) | 신규 복소환(複素環) 화합물의 제법 | |
| ES463783A1 (es) | Un procedimiento para la preparacion de cis-4a-aril-octahi- dro-1h-2-pirindinas 2-sustituidas. | |
| KR830006302A (ko) | 신규 피리미딘 유도체의 제조방법 | |
| KR890014464A (ko) | 아릴술포닐알킬아미드의 합성방법 | |
| KR850001738A (ko) | 측쇄기로서 니트로메틸렌기를 갖는 헤테로고리 화합물을 제조하는 방법 | |
| KR870002049A (ko) | 6-치환된 안드로스타-1,4-디엔-3,7-디온 유도체의 제조 방법 | |
| KR890002011A (ko) | 5-할로 게노-6-아미노-니코틴산 할라이드. 이의 제조방법 및 용도 | |
| KR920019742A (ko) | L-프롤린 유도체의 제조방법 | |
| KR830009043A (ko) | 4-(1-이미다졸일메틸)신남산 하이드로클로라이드 모노하이드레이트의 제조방법 | |
| KR840008647A (ko) | 대칭 1,4-디하이드로피리딘디카복실 에스테르의 제조방법 | |
| KR830009000A (ko) | 2-벤조일아미노-치환벤질아민 유도체 및 그 제조방법 | |
| KR840003642A (ko) | 에르고트 5's-(2r-부틸)펩티드 알카로이드의 제조방법 | |
| KR950032074A (ko) | β-니트로엔아민 및 그의 중간체의 제조 방법 | |
| KR830002718A (ko) | 피라졸 유도체의 제조법 | |
| KR850000454A (ko) | 세팔로스포린 유도체의 제조방법 | |
| KR840002848A (ko) | 유기인산염의 제조방법 | |
| KR840000476A (ko) | 제초성 n-할로아세틸-2-알킬-6-아실아닐린 및 이의 유도체의 제조 방법 | |
| KR840001172A (ko) | 편두통 치료제인 트로필 벤조에이트 유도체의 제조방법 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PA0109 | Patent application |
St.27 status event code: A-0-1-A10-A12-nap-PA0109 |
|
| R17-X000 | Change to representative recorded |
St.27 status event code: A-3-3-R10-R17-oth-X000 |
|
| PG1501 | Laying open of application |
St.27 status event code: A-1-1-Q10-Q12-nap-PG1501 |
|
| P11-X000 | Amendment of application requested |
St.27 status event code: A-2-2-P10-P11-nap-X000 |
|
| P13-X000 | Application amended |
St.27 status event code: A-2-2-P10-P13-nap-X000 |
|
| PA0201 | Request for examination |
St.27 status event code: A-1-2-D10-D11-exm-PA0201 |
|
| PE0902 | Notice of grounds for rejection |
St.27 status event code: A-1-2-D10-D21-exm-PE0902 |
|
| P11-X000 | Amendment of application requested |
St.27 status event code: A-2-2-P10-P11-nap-X000 |
|
| P13-X000 | Application amended |
St.27 status event code: A-2-2-P10-P13-nap-X000 |
|
| PG1605 | Publication of application before grant of patent |
St.27 status event code: A-2-2-Q10-Q13-nap-PG1605 |
|
| PE0701 | Decision of registration |
St.27 status event code: A-1-2-D10-D22-exm-PE0701 |
|
| PR0701 | Registration of establishment |
St.27 status event code: A-2-4-F10-F11-exm-PR0701 |
|
| PR1002 | Payment of registration fee |
St.27 status event code: A-2-2-U10-U11-oth-PR1002 Fee payment year number: 1 |
|
| PR1001 | Payment of annual fee |
St.27 status event code: A-4-4-U10-U11-oth-PR1001 Fee payment year number: 4 |
|
| PR1001 | Payment of annual fee |
St.27 status event code: A-4-4-U10-U11-oth-PR1001 Fee payment year number: 12 |
|
| PR1001 | Payment of annual fee |
St.27 status event code: A-4-4-U10-U11-oth-PR1001 Fee payment year number: 13 |
|
| PC1903 | Unpaid annual fee |
St.27 status event code: A-4-4-U10-U13-oth-PC1903 Not in force date: 20021118 Payment event data comment text: Termination Category : DEFAULT_OF_REGISTRATION_FEE |
|
| PC1903 | Unpaid annual fee |
St.27 status event code: N-4-6-H10-H13-oth-PC1903 Ip right cessation event data comment text: Termination Category : DEFAULT_OF_REGISTRATION_FEE Not in force date: 20021118 |
|
| PN2301 | Change of applicant |
St.27 status event code: A-5-5-R10-R13-asn-PN2301 St.27 status event code: A-5-5-R10-R11-asn-PN2301 |
|
| PN2301 | Change of applicant |
St.27 status event code: A-5-5-R10-R13-asn-PN2301 St.27 status event code: A-5-5-R10-R11-asn-PN2301 |
|
| R18-X000 | Changes to party contact information recorded |
St.27 status event code: A-5-5-R10-R18-oth-X000 |
|
| R18-X000 | Changes to party contact information recorded |
St.27 status event code: A-5-5-R10-R18-oth-X000 |
|
| PN2301 | Change of applicant |
St.27 status event code: A-5-5-R10-R13-asn-PN2301 St.27 status event code: A-5-5-R10-R11-asn-PN2301 |